• Western blot analysis of various cells using CD298 Polyclonal Antibody diluted at 1:1000

Anti-ATP1B3 antibody (60-140 aa) (STJ92110)

SKU:
STJ92110

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Rat/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Sodium/potassium-transporting ATPase subunit beta-3 (60-140 aa) is suitable for use in Western Blot and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
ELISA 1:10000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: ATP1B3
Gene ID: 483
Uniprot ID: AT1B3_HUMAN
Immunogen Region: 60-140 aa
Specificity: CD298 Polyclonal Antibody detects endogenous levels of CD298 protein.
Immunogen: Synthesized peptide derived from Human N-ternal CD298 at the amino acid range 60-140
Protein Name Sodium/Potassium-Transporting Atpase Subunit Beta-3
Sodium/Potassium-Dependent Atpase Subunit Beta-3
Atpb-3
Cd Antigen Cd298
Database Links Reactome: R-HSA-210991
Reactome: R-HSA-5578775
Reactome: R-HSA-936837
Reactome: R-HSA-9679191
Cellular Localisation Apical Cell Membrane
Single-Pass Type Ii Membrane Protein
Basolateral Cell Membrane
Melanosome
Identified By Mass Spectrometry In Melanosome Fractions From Stage I To Stage Iv
Alternative Antibody Names Anti-Sodium/Potassium-Transporting Atpase Subunit Beta-3 antibody
Anti-Sodium/Potassium-Dependent Atpase Subunit Beta-3 antibody
Anti-Atpb-3 antibody
Anti-Cd Antigen Cd298 antibody
Anti-ATP1B3 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance